Haemophilia  ||| S:0 E:12 ||| JJ
patients  ||| S:12 E:21 ||| NNS
with  ||| S:21 E:26 ||| IN
HIV-  ||| S:26 E:31 ||| JJ
and  ||| S:31 E:35 ||| CC
HCV-infection ||| S:35 E:48 ||| JJ
.  ||| S:48 E:50 ||| .
Long  ||| S:50 E:55 ||| JJ
term  ||| S:55 E:60 ||| NN
survival  ||| S:60 E:69 ||| NN
At  ||| S:69 E:72 ||| IN
present  ||| S:72 E:80 ||| JJ
( ||| S:80 E:81 ||| -LRB-
2010 ||| S:81 E:85 ||| CD
) ||| S:85 E:86 ||| -RRB-
,  ||| S:86 E:88 ||| ,
we  ||| S:88 E:91 ||| PRP
investigate  ||| S:91 E:103 ||| VB
in  ||| S:103 E:106 ||| IN
a  ||| S:106 E:108 ||| DT
long  ||| S:108 E:113 ||| JJ
term  ||| S:113 E:118 ||| NN
study  ||| S:118 E:124 ||| NN
on  ||| S:124 E:127 ||| IN
psychosocial  ||| S:127 E:140 ||| JJ
aspects  ||| S:140 E:148 ||| NNS
of  ||| S:148 E:151 ||| IN
haemophilia  ||| S:151 E:163 ||| NN
at  ||| S:163 E:166 ||| IN
the  ||| S:166 E:170 ||| DT
Munich  ||| S:170 E:177 ||| NNP
Haemophilia  ||| S:177 E:189 ||| NNP
Centre  ||| S:189 E:196 ||| NNP
factors  ||| S:196 E:204 ||| NNS
which  ||| S:204 E:210 ||| WDT
could  ||| S:210 E:216 ||| MD
be  ||| S:216 E:219 ||| VB
held  ||| S:219 E:224 ||| VBN
responsible  ||| S:224 E:236 ||| JJ
for  ||| S:236 E:240 ||| IN
the  ||| S:240 E:244 ||| DT
large  ||| S:244 E:250 ||| JJ
number  ||| S:250 E:257 ||| NN
of  ||| S:257 E:260 ||| IN
still  ||| S:260 E:266 ||| RB
living  ||| S:266 E:273 ||| VBG
HIV+  ||| S:273 E:278 ||| CD
patients  ||| S:278 E:287 ||| NNS
while  ||| S:287 E:293 ||| IN
many  ||| S:293 E:298 ||| JJ
patients  ||| S:298 E:307 ||| NNS
died  ||| S:307 E:312 ||| VBD
from  ||| S:312 E:317 ||| IN
AIDS  ||| S:317 E:322 ||| NNP
or  ||| S:322 E:325 ||| CC
from  ||| S:325 E:330 ||| IN
diseases  ||| S:330 E:339 ||| NNS
caused  ||| S:339 E:346 ||| VBN
by  ||| S:346 E:349 ||| IN
HCV  ||| S:349 E:353 ||| NNP
during  ||| S:353 E:360 ||| IN
the  ||| S:360 E:364 ||| DT
1990ies ||| S:364 E:371 ||| NN
.  ||| S:371 E:373 ||| .
We  ||| S:373 E:376 ||| PRP
retrospectively  ||| S:376 E:392 ||| RB
compare  ||| S:392 E:400 ||| VB
medical  ||| S:400 E:408 ||| JJ
and  ||| S:408 E:412 ||| CC
psychosocial  ||| S:412 E:425 ||| JJ
data  ||| S:425 E:430 ||| NNS
of  ||| S:430 E:433 ||| IN
15  ||| S:433 E:436 ||| CD
HIV+  ||| S:436 E:441 ||| CD
long  ||| S:441 E:446 ||| JJ
term  ||| S:446 E:451 ||| NN
survivors  ||| S:451 E:461 ||| NNS
( ||| S:461 E:462 ||| -LRB-
L-S ||| S:462 E:465 ||| NNP
) ||| S:465 E:466 ||| -RRB-
,  ||| S:466 E:468 ||| ,
15  ||| S:468 E:471 ||| CD
HIV+  ||| S:471 E:476 ||| CD
later  ||| S:476 E:482 ||| RB
on  ||| S:482 E:485 ||| IN
deceased  ||| S:485 E:494 ||| JJ
patients  ||| S:494 E:503 ||| NNS
and  ||| S:503 E:507 ||| CC
15  ||| S:507 E:510 ||| CD
HIV- ||| S:510 E:514 ||| NN
,  ||| S:514 E:516 ||| ,
all  ||| S:516 E:520 ||| DT
of  ||| S:520 E:523 ||| IN
them  ||| S:523 E:528 ||| PRP
deriving  ||| S:528 E:537 ||| VBD
from  ||| S:537 E:542 ||| IN
the  ||| S:542 E:546 ||| DT
original  ||| S:546 E:555 ||| JJ
investigation  ||| S:555 E:569 ||| NN
group  ||| S:569 E:575 ||| NN
from  ||| S:575 E:580 ||| IN
1985  ||| S:580 E:585 ||| CD
including  ||| S:585 E:595 ||| VBG
52  ||| S:595 E:598 ||| CD
patients  ||| S:598 E:607 ||| NNS
( ||| S:607 E:608 ||| -LRB-
30  ||| S:608 E:611 ||| CD
HIV+ ||| S:611 E:615 ||| CD
,  ||| S:615 E:617 ||| ,
22  ||| S:617 E:620 ||| CD
HIV- ||| S:620 E:624 ||| NN
) ||| S:624 E:625 ||| -RRB-
.  ||| S:625 E:627 ||| .
We  ||| S:627 E:630 ||| PRP
prove  ||| S:630 E:636 ||| VB
the  ||| S:636 E:640 ||| DT
validity  ||| S:640 E:649 ||| NN
of  ||| S:649 E:652 ||| IN
our  ||| S:652 E:656 ||| PRP$
psychosocial  ||| S:656 E:669 ||| JJ
factors  ||| S:669 E:677 ||| NNS
by  ||| S:677 E:680 ||| IN
the  ||| S:680 E:684 ||| DT
SF  ||| S:684 E:687 ||| NNP
36  ||| S:687 E:690 ||| CD
which  ||| S:690 E:696 ||| WDT
currently  ||| S:696 E:706 ||| RB
serves  ||| S:706 E:713 ||| VBZ
as  ||| S:713 E:716 ||| RB
gold  ||| S:716 E:721 ||| JJ
standard ||| S:721 E:729 ||| NN
.  ||| S:729 E:731 ||| .
The  ||| S:731 E:735 ||| DT
actual  ||| S:735 E:742 ||| JJ
psychosocial  ||| S:742 E:755 ||| JJ
factors  ||| S:755 E:763 ||| NNS
and  ||| S:763 E:767 ||| CC
medical  ||| S:767 E:775 ||| JJ
parameters  ||| S:775 E:786 ||| NNS
of  ||| S:786 E:789 ||| IN
the  ||| S:789 E:793 ||| DT
15  ||| S:793 E:796 ||| CD
L-S  ||| S:796 E:800 ||| NNS
are  ||| S:800 E:804 ||| VBP
checked  ||| S:804 E:812 ||| VBN
against  ||| S:812 E:820 ||| IN
the  ||| S:820 E:824 ||| DT
data  ||| S:824 E:829 ||| NNS
of  ||| S:829 E:832 ||| IN
the  ||| S:832 E:836 ||| DT
15  ||| S:836 E:839 ||| CD
HIV-  ||| S:839 E:844 ||| JJ
patients ||| S:844 E:852 ||| NNS
.  ||| S:852 E:854 ||| .
In  ||| S:854 E:857 ||| IN
1985  ||| S:857 E:862 ||| CD
already ||| S:862 E:869 ||| RB
,  ||| S:869 E:871 ||| ,
we  ||| S:871 E:874 ||| PRP
retrospectively  ||| S:874 E:890 ||| VBP
found  ||| S:890 E:896 ||| VBN
significantly  ||| S:896 E:910 ||| RB
higher  ||| S:910 E:917 ||| JJR
values  ||| S:917 E:924 ||| NNS
regarding  ||| S:924 E:934 ||| VBG
psychosocial  ||| S:934 E:947 ||| JJ
factors  ||| S:947 E:955 ||| NNS
within  ||| S:955 E:962 ||| IN
the  ||| S:962 E:966 ||| DT
group  ||| S:966 E:972 ||| NN
of  ||| S:972 E:975 ||| IN
the  ||| S:975 E:979 ||| DT
L-S  ||| S:979 E:983 ||| JJ
as  ||| S:983 E:986 ||| IN
opposed  ||| S:986 E:994 ||| VBN
to  ||| S:994 E:997 ||| TO
the  ||| S:997 E:1001 ||| DT
later  ||| S:1001 E:1007 ||| RBR
on  ||| S:1007 E:1010 ||| IN
deceased  ||| S:1010 E:1019 ||| JJ
ones ||| S:1019 E:1023 ||| NNS
.  ||| S:1023 E:1025 ||| .
Highly  ||| S:1025 E:1032 ||| RB
significant  ||| S:1032 E:1044 ||| JJ
are  ||| S:1044 E:1048 ||| VBP
the  ||| S:1048 E:1052 ||| DT
facts  ||| S:1052 E:1058 ||| NNS
that  ||| S:1058 E:1063 ||| IN
more  ||| S:1063 E:1068 ||| JJR
than  ||| S:1068 E:1073 ||| IN
90  ||| S:1073 E:1076 ||| CD
%  ||| S:1076 E:1078 ||| NN
of  ||| S:1078 E:1081 ||| IN
HIV+  ||| S:1081 E:1086 ||| CD
L-S  ||| S:1086 E:1090 ||| NNS
have  ||| S:1090 E:1095 ||| VBP
had  ||| S:1095 E:1099 ||| VBN
a  ||| S:1099 E:1101 ||| DT
good  ||| S:1101 E:1106 ||| JJ
relationship  ||| S:1106 E:1119 ||| NN
to  ||| S:1119 E:1122 ||| TO
their  ||| S:1122 E:1128 ||| PRP$
fathers  ||| S:1128 E:1136 ||| NNS
and  ||| S:1136 E:1140 ||| CC
are  ||| S:1140 E:1144 ||| VBP
still  ||| S:1144 E:1150 ||| RB
employed  ||| S:1150 E:1159 ||| VBN
today  ||| S:1159 E:1165 ||| NN
in  ||| S:1165 E:1168 ||| IN
contrast  ||| S:1168 E:1177 ||| NN
to  ||| S:1177 E:1180 ||| TO
the  ||| S:1180 E:1184 ||| DT
deceased  ||| S:1184 E:1193 ||| JJ
HIV+  ||| S:1193 E:1198 ||| CD
patients ||| S:1198 E:1206 ||| NNS
.  ||| S:1206 E:1208 ||| .
At  ||| S:1208 E:1211 ||| IN
present ||| S:1211 E:1218 ||| JJ
,  ||| S:1218 E:1220 ||| ,
the  ||| S:1220 E:1224 ||| DT
differences  ||| S:1224 E:1236 ||| NNS
regarding  ||| S:1236 E:1246 ||| VBG
psychosocial  ||| S:1246 E:1259 ||| JJ
factors  ||| S:1259 E:1267 ||| NNS
between  ||| S:1267 E:1275 ||| IN
HIV+  ||| S:1275 E:1280 ||| NNP
L-S  ||| S:1280 E:1284 ||| NNP
and  ||| S:1284 E:1288 ||| CC
HIV-negative  ||| S:1288 E:1301 ||| JJ
patients  ||| S:1301 E:1310 ||| NNS
are  ||| S:1310 E:1314 ||| VBP
vanishing ||| S:1314 E:1323 ||| VBG
.  ||| S:1323 E:1325 ||| .
